Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T13:25:21.807Z.
Calculation as of: 2026-10-06T13:25:21.807Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 397c5a59cd83d044dab6d82224f034cfcc72b23d5b6e8de026e21d37d80d55f6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-11-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$228.41M
EV/EBIT Ratio
N/A
TTM Avg
1.44x
3Y Avg
1.44x
5Y Avg
1.44x
Market Cap
$239.89M
EV/EBIT Ratio
100.19x
TTM Avg
177.33x
3Y Avg
172.45x
5Y Avg
172.45x
Market Cap
$244.25M
EV/EBIT Ratio
N/A
TTM Avg
245.87x
3Y Avg
245.87x
5Y Avg
245.87x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alector, Inc. (ALEC) | $220.94M | N/A | N/A | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $218.42M | 6.97x | 6.24x | 9.86x | 9.86x |
| Keros Therapeutics, Inc. (KROS)vs › | $228.41M | N/A | 1.44x | 1.44x | 1.44x |
| Electra Therapeutics Inc. (ETRA)vs › | $206.61M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $236.56M | N/A | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $239.45M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $202.05M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $239.89M | 100.19x | 177.33x | 172.45x | 172.45x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $244.25M | N/A | 245.87x | 245.87x | 245.87x |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.56M | N/A | 98.16x | 1055.07x | 378.93x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2022-11-08 | 16.18x |
| 2022-11-07 | 15.84x |
| 2022-11-04 | 15.50x |
| 2022-11-03 | 16.25x |
| 2022-11-02 | 17.20x |
| 2022-11-01 | 17.82x |
| 2022-10-31 | 17.61x |
| 2022-10-28 | 18.34x |
| 2022-10-27 | 17.08x |
| 2022-10-26 | 17.40x |
| 2022-10-25 | 17.22x |
| 2022-10-24 | 16.55x |
| 2022-10-21 | 16.87x |
| 2022-10-20 | 16.58x |
| 2022-10-19 | 16.92x |
| 2022-10-18 | 17.61x |
| 2022-10-17 | 17.86x |
| 2022-10-14 | 16.09x |
| 2022-10-13 | 16.94x |
| 2022-10-12 | 16.87x |
| 2022-10-11 | 17.13x |
| 2022-10-10 | 16.25x |
| 2022-10-07 | 16.41x |
| 2022-10-06 | 17.45x |
| 2022-10-05 | 17.70x |
| 2022-10-04 | 18.41x |
| 2022-10-03 | 17.88x |
| 2022-09-30 | 18.21x |
| 2022-09-29 | 18.18x |
| 2022-09-28 | 18.28x |
| 2022-09-27 | 15.98x |
| 2022-09-26 | 15.29x |
| 2022-09-23 | 15.84x |
| 2022-09-22 | 16.67x |
| 2022-09-21 | 16.97x |
| 2022-09-20 | 17.77x |
| 2022-09-19 | 18.00x |
| 2022-09-16 | 17.68x |
| 2022-09-15 | 19.01x |
| 2022-09-14 | 18.71x |
| 2022-09-13 | 17.70x |
| 2022-09-12 | 19.84x |
| 2022-09-09 | 18.59x |
| 2022-09-08 | 21.72x |
| 2022-09-07 | 21.10x |
| 2022-09-06 | 19.22x |
| 2022-09-02 | 20.50x |
| 2022-09-01 | 21.22x |
| 2022-08-31 | 20.25x |
| 2022-08-30 | 20.83x |
| 2022-08-29 | 20.85x |
| 2022-08-26 | 21.33x |
| 2022-08-25 | 23.01x |
| 2022-08-24 | 22.96x |
| 2022-08-23 | 22.73x |
| 2022-08-22 | 22.46x |
| 2022-08-19 | 23.15x |
| 2022-08-18 | 23.77x |
| 2022-08-17 | 23.65x |
| 2022-08-16 | 24.66x |
| 2022-08-15 | 26.09x |
| 2022-08-12 | 26.80x |
| 2022-08-11 | 25.56x |
| 2022-08-10 | 26.34x |
| 2022-08-09 | 25.56x |
| 2022-08-08 | 26.61x |
| 2022-08-05 | 26.48x |
